These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

806 related articles for article (PubMed ID: 20829328)

  • 21. The structure of blood-tumor barrier and distribution of chemotherapeutic drugs in non-small cell lung cancer brain metastases.
    Ye LY; Sun LX; Zhong XH; Chen XS; Hu S; Xu RR; Zeng XN; Xie WP; Kong H
    Cancer Cell Int; 2021 Oct; 21(1):556. PubMed ID: 34689774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoparticles Containing a Combination of a Drug and an Antibody for the Treatment of Breast Cancer Brain Metastases.
    Wyatt EA; Davis ME
    Mol Pharm; 2020 Feb; 17(2):717-721. PubMed ID: 31916770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphodiesterase type 5 inhibitors increase Herceptin transport and treatment efficacy in mouse metastatic brain tumor models.
    Hu J; Ljubimova JY; Inoue S; Konda B; Patil R; Ding H; Espinoza A; Wawrowsky KA; Patil C; Ljubimov AV; Black KL
    PLoS One; 2010 Apr; 5(4):e10108. PubMed ID: 20419092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer.
    Taskar KS; Rudraraju V; Mittapalli RK; Samala R; Thorsheim HR; Lockman J; Gril B; Hua E; Palmieri D; Polli JW; Castellino S; Rubin SD; Lockman PR; Steeg PS; Smith QR
    Pharm Res; 2012 Mar; 29(3):770-81. PubMed ID: 22011930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution analysis of epertinib in brain metastasis of HER2-positive breast cancer by imaging mass spectrometry and prospect for antitumor activity.
    Tanaka Y; Hirata M; Shinonome S; Torii M; Nezasa KI; Tanaka H
    Sci Rep; 2018 Jan; 8(1):343. PubMed ID: 29321587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis.
    Lewis Phillips GD; Nishimura MC; Lacap JA; Kharbanda S; Mai E; Tien J; Malesky K; Williams SP; Marik J; Phillips HS
    Breast Cancer Res Treat; 2017 Aug; 164(3):581-591. PubMed ID: 28493046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases.
    Bernatz S; Ilina EI; Devraj K; Harter PN; Mueller K; Kleber S; Braun Y; Penski C; Renner C; Halder R; Jennewein L; Solbach C; Thorsen F; Pestalozzi BC; Mischo A; Mittelbronn M
    J Exp Clin Cancer Res; 2019 Oct; 38(1):434. PubMed ID: 31665089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.
    Hu J; Yuan X; Ko MK; Yin D; Sacapano MR; Wang X; Konda BM; Espinoza A; Prosolovich K; Ong JM; Irvin D; Black KL
    Mol Cancer; 2007 Mar; 6():22. PubMed ID: 17359538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer.
    Adkins CE; Nounou MI; Hye T; Mohammad AS; Terrell-Hall T; Mohan NK; Eldon MA; Hoch U; Lockman PR
    BMC Cancer; 2015 Oct; 15():685. PubMed ID: 26463521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel-hyaluronic nanoconjugates prolong overall survival in a preclinical brain metastases of breast cancer model.
    Mittapalli RK; Liu X; Adkins CE; Nounou MI; Bohn KA; Terrell TB; Qhattal HS; Geldenhuys WJ; Palmieri D; Steeg PS; Smith QR; Lockman PR
    Mol Cancer Ther; 2013 Nov; 12(11):2389-99. PubMed ID: 24002934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvianolic acid A increases the accumulation of doxorubicin in brain tumors through Caveolae endocytosis.
    Zhang C; Pan Y; Cai R; Guo S; Zhang X; Xue Y; Wang J; Huang J; Wang J; Gu Y; Zhang Z
    Neuropharmacology; 2020 May; 167():107980. PubMed ID: 32014448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine.
    Kim M; Kizilbash SH; Laramy JK; Gampa G; Parrish KE; Sarkaria JN; Elmquist WF
    Pharm Res; 2018 Jul; 35(9):177. PubMed ID: 30003344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approach.
    Percy DB; Ribot EJ; Chen Y; McFadden C; Simedrea C; Steeg PS; Chambers AF; Foster PJ
    Invest Radiol; 2011 Nov; 46(11):718-25. PubMed ID: 21788908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to Make Anticancer Drugs Cross the Blood-Brain Barrier to Treat Brain Metastases.
    Angeli E; Nguyen TT; Janin A; Bousquet G
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
    Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.
    Arvanitis CD; Ferraro GB; Jain RK
    Nat Rev Cancer; 2020 Jan; 20(1):26-41. PubMed ID: 31601988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity and vascular permeability of breast cancer brain metastases.
    Babak MV; Zalutsky MR; Balyasnikova IV
    Cancer Lett; 2020 Oct; 489():174-181. PubMed ID: 32561415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inducing a Transient Increase in Blood-Brain Barrier Permeability for Improved Liposomal Drug Therapy of Glioblastoma Multiforme.
    Lundy DJ; Lee KJ; Peng IC; Hsu CH; Lin JH; Chen KH; Tien YW; Hsieh PCH
    ACS Nano; 2019 Jan; 13(1):97-113. PubMed ID: 30532951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cells.
    Fitzgerald DP; Emerson DL; Qian Y; Anwar T; Liewehr DJ; Steinberg SM; Silberman S; Palmieri D; Steeg PS
    Mol Cancer Ther; 2012 Sep; 11(9):1959-67. PubMed ID: 22622283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood-brain barrier targeting brain metastases of breast cancer.
    Li J; Cai P; Shalviri A; Henderson JT; He C; Foltz WD; Prasad P; Brodersen PM; Chen Y; DaCosta R; Rauth AM; Wu XY
    ACS Nano; 2014 Oct; 8(10):9925-40. PubMed ID: 25307677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.